Biolife Solutions (BLFS) Accounts Payables (2010 - 2026)

Biolife Solutions (BLFS) has 17 years of Accounts Payables data on file, last reported at $3.8 million in Q1 2026.

• Accounts Payables for Q1 2026 came in at $3.8 million, up 13.74% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.8 million (up 13.74% YoY), and the FY2025 annual result was $1.5 million, down 55.77% from the prior year.
• Accounts Payables grew to $3.8 million in Q1 2026 per BLFS's latest filing, from $1.5 million in the prior quarter.
• Over five years, Accounts Payables peaked at $15.5 million in Q1 2023 and troughed at $1.5 million in Q4 2025.
• A 5-year average of $7.2 million and a median of $4.2 million in 2024 frame the typical range for Accounts Payables.
• The sharpest annual moves came in 2022 and 2023: Accounts Payables soared 173.88% in 2022, then plunged 85.23% in 2023.
• A 5-year view of Accounts Payables shows it stood at $15.4 million in 2022, then slumped by 85.23% to $2.3 million in 2023, then jumped by 48.02% to $3.4 million in 2024, then tumbled by 55.77% to $1.5 million in 2025, then surged by 152.36% to $3.8 million in 2026.
• Business Quant data shows BLFS's Accounts Payables at $3.8 million in Q1 2026, $1.5 million in Q4 2025, and $2.9 million in Q3 2025.